# Sequencing in Inflammatory Bowel Diseases (IBD) Therapy: "the Latium Net".

> **NCT06603337** · — · RECRUITING · sponsor: **Fondazione Policlinico Universitario Agostino Gemelli IRCCS** · enrollment: 2700 (estimated)

## Conditions studied

- IBD (Inflammatory Bowel Disease)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06603337
- **Lead sponsor:** Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-18
- **Primary completion:** 2026-10-01
- **Final completion:** 2028-10-01
- **Target enrollment:** 2700 (ESTIMATED)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06603337

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06603337, "Sequencing in Inflammatory Bowel Diseases (IBD) Therapy: "the Latium Net".". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06603337. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*